Motor effects of a dopamine stabilizer (GMC1111) in primate models of Parkinson and hemiparkinsonism

Author： Klintenberg R.   Arts J.   Jongsma M.   Wikstrom H.   Gunne L.   Andren P.E.  

Publisher： Elsevier

ISSN： 0014-2999

Source： European Journal of Pharmacology, Vol.459, Iss.2, 2003-01, pp. : 231-237

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Motor effects of lamotrigine in naive and dopamine-depleted mice

By Kaur S.   Starr M.  

European Journal of Pharmacology, Vol. 304, Iss. 1, 1996-05 ,pp. : 1-6

Elsevier

Access to resources Recommend Favorite

Some complementary therapies have possible effects on the motor symptoms of Parkinson's disease

By  

Drugs & Therapy Perspectives, Vol. 26, Iss. 7, 2010-07 ,pp. : 10-13

Adis International

Access to resources Recommend Favorite

Clinical Review and Treatment of Select Adverse Effects of Dopamine Receptor Agonists in Parkinson's Disease

By Wood Lindy D.  

Drugs & Aging, Vol. 27, Iss. 4, 2010-04 ,pp. : 295-310

Adis International

Access to resources Recommend Favorite

Use various methods to manage the nonmotor adverse effects of dopamine receptor agonists in Parkinson's disease

By  

Drugs & Therapy Perspectives, Vol. 26, Iss. 12, 2010-12 ,pp. : 23-26

Adis International

Access to resources Recommend Favorite

Dopamine agonists in Parkinson’s disease

By Tintner Ron   Jankovic Joseph  

Expert Opinion on Investigational Drugs, Vol. 12, Iss. 11, 2003-11 ,pp. : 1803-1820

Informa Healthcare

Access to resources Recommend Favorite